Catalys Pacific, Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 5, 2026, Catalys Pacific, Llc disclosed 2 stock positions valued at approximately $229.45M as of quarter-end June 30, 2026. The largest holdings include Mineralys Therapeutics, Inc. and Phathom Pharmaceuticals, Inc..

Report Period
June 30, 2026
No. of Stocks
2
Portfolio Value
$229.45M
Holdings by Sector
Catalys Pacific, Llc Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
Mineralys Therapeutics, Inc.MLYSHealthcare92.94%7,903,838--$213,245,549
Phathom Pharmaceuticals, Inc.PHATHealthcare7.06%1,493,854--$16,208,316
Showing 2 of 2 holdings in the latest reporting period.